{"organizations": [], "uuid": "f9c59468e9ef7ed08e59c39dcde823662393954f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-corriente-advisors-reports-73-pct/brief-corriente-advisors-reports-7-3-pct-passive-stake-in-catabasis-pharmaceuticals-idUSFWN1QD160", "country": "US", "domain_rank": 408, "title": "BRIEF-Corriente Advisors Reports 7.3 Pct Passive Stake In Catabasis Pharmaceuticals‍​", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-23T15:46:00.000+02:00", "replies_count": 0, "uuid": "f9c59468e9ef7ed08e59c39dcde823662393954f"}, "author": "", "url": "https://www.reuters.com/article/brief-corriente-advisors-reports-73-pct/brief-corriente-advisors-reports-7-3-pct-passive-stake-in-catabasis-pharmaceuticals-idUSFWN1QD160", "ord_in_thread": 0, "title": "BRIEF-Corriente Advisors Reports 7.3 Pct Passive Stake In Catabasis Pharmaceuticals‍​", "locations": [], "entities": {"persons": [], "locations": [{"name": "catabasis", "sentiment": "none"}], "organizations": [{"name": "sec", "sentiment": "none"}, {"name": "catabasis pharmaceuticals inc", "sentiment": "none"}, {"name": "stake in catabasis pharmaceuticals‍​ reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 23, 2018 / 1:50 PM / Updated 13 minutes ago BRIEF-Corriente Advisors Reports 7.3 Pct Passive Stake In Catabasis Pharmaceuticals‍​ Reuters Staff 1 Min Read Feb 23 (Reuters) - Catabasis Pharmaceuticals Inc: * CORRIENTE ADVISORS LLC REPORTS 7.3 PERCENT PASSIVE STAKE IN CATABASIS PHARMACEUTICALS INC AS OF FEBRUARY 16, 2018 - SEC FILING‍​ Source text : ( bit.ly/2CDqdMi ) Further company coverage:", "external_links": [], "published": "2018-02-23T15:46:00.000+02:00", "crawled": "2018-02-23T16:12:12.001+02:00", "highlightTitle": ""}